D.E. Shaw & Co’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-11,078	Closed	-$91K	–	5604
2021 Q2	$91K	Sell	11,078 -52,563	-83%	-$447K	﹤0.01%	4565
2021 Q1	$570K	Sell	63,641 -14,773	-19%	-$169K	﹤0.01%	3448
2020 Q4	$905K	Sell	78,414 -158,596	-67%	-$1.84M	﹤0.01%	3080
2020 Q3	$2.47M	Sell	237,010 -466,669	-66%	-$5.72M	﹤0.01%	2242
2020 Q2	$9.25M	Buy	703,679 +250,185	+55%	+$2.59M	0.01%	1231
2020 Q1	$3.57M	Buy	453,494 +132,787	+41%	+$2M	0.01%	1726
2019 Q4	$6.64M	Sell	320,707 -300,236	-48%	-$5.06M	0.01%	1508
2019 Q3	$8.51M	Buy	620,943 +75,886	+14%	+$900K	0.01%	1269
2019 Q2	$6.7M	Buy	545,057 +90,204	+20%	+$1.04M	0.01%	1385
2019 Q1	$5.68M	Buy	454,853 +204,451	+82%	+$2.73M	0.01%	1465
2018 Q4	$2.83M	Buy	250,402 +209,809	+517%	+$3.29M	0.01%	1884
2018 Q3	$759K	Sell	40,593 -25,906	-39%	-$595K	﹤0.01%	2859
2018 Q2	$1.72M	Buy	+66,499	New	+$1.73M	﹤0.01%	2353
2017 Q4	–	Sell	-105,458	Closed	-$2.55M	–	3853
2017 Q3	$2.55M	Buy	105,458 +69,401	+192%	+$1.63M	0.01%	1852
2017 Q2	$729K	Sell	36,057 -19,248	-35%	-$401K	﹤0.01%	2608
2017 Q1	$1.49M	Buy	55,305 +33,205	+150%	+$678K	﹤0.01%	2037
2016 Q4	$420K	Buy	+22,100	New	+$422K	﹤0.01%	2952
2016 Q2	–	Sell	-92,815	Closed	-$854K	–	3636
2016 Q1	$854K	Buy	92,815 +66,060	+247%	+$801K	﹤0.01%	2461
2015 Q4	$516K	Sell	26,755 -24,170	-47%	-$420K	﹤0.01%	3074
2015 Q3	$757K	Buy	+50,925	New	+$1.19M	﹤0.01%	2795

Other funds holding FLXN